Norris ORIEN Total Cancer Care
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Southern California
About this trial
This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Limited to those patients who are registered for outpatient or inpatient care at University of Southern California (USC) Norris
Able to understand and sign the TCCP informed consent, California subject's bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject's bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages
Disqualifiers
Individuals who are not registered as patients for outpatient or inpatient care at USC Norris
Individuals who are unable to understand or sign the TCCP informed consent, subject's bill of rights, HIPAA, and research authorization in either English or Spanish
Trial population
Patients with cancer or predisposition for cancer recruited from University of Southern California/Kenneth Norris, Jr. Comprehensive Cancer Center and Hospital
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Biospecimen Collection
Procedure/SurgeryUndergo collection of blood, tissue, and other biological samples
Evaluation of Cancer Risk Factors
Procedure/SurgeryAncillary studies
Medical Chart Review
Other interventionReview of medical chart
Quality-of-Life Assessment
Other interventionAncillary studies
Questionnaire Administration
Other interventionAncillary studies
Treatment groups
10,000 Participants
are divided into 1 treatment groupGroup A: Ancillary-Correlative (biospecimen collection)5 interventions
Trial outcomes
Primary outcomes
1
Number of biospecimen collected for a centralized repository that is linked to clinical data
Establish and maintain a unique repository of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) collected from thousands of patients 18 years of age or older who have cancer or are at risk of developing cancer.
Time frame
Up to 21 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov